We previously demonstrated that TRPV2 knockdown enhances the stemness of cancer stem-like cells through increased expression levels of cancer stem cell markers ALDH1, CD133, and CD44 (Hu et al. 2018). This evidence concerns the gene ALDH1A1 and cancer.